A GBT021601 ADME Microtracer Study in Healthy Volunteers
Status:
Active, not recruiting
Trial end date:
2023-08-11
Target enrollment:
Participant gender:
Summary
An Open-label Study of GBT021601 in 8 to 10 healthy male or female participants to evaluate
the absorption, distribution, metabolism, and excretion (ADME) of GBT021601.